4//SEC Filing
Yang Arvin 4
Accession 0001104659-20-131574
CIK 0001442836other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:30 PM ET
Size
7.8 KB
Accession
0001104659-20-131574
Insider Transaction Report
Form 4
Yang Arvin
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-11-30+200,000→ 200,000 totalExercise: $25.48Exp: 2030-11-29→ Common Stock (200,000 underlying) - Award
Restricted stock unit
2020-11-30+37,000→ 37,000 totalExp: 2030-11-29→ Common Stock (37,000 underlying)
Footnotes (3)
- [F1]The options will vest as to 25% of the shares on the first anniversary of the grant date and in equal quarterly installments over the next three years.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- [F3]The restricted stock units will vest as to 50% of the shares on the first anniversary of the grant date and 50% of the shares on the second anniversary of the grant date.
Documents
Issuer
Mersana Therapeutics, Inc.
CIK 0001442836
Entity typeother
Related Parties
1- filerCIK 0001834321
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 4:30 PM ET
- Size
- 7.8 KB